Beijing Scitop Bio Tech Co Ltd (SHE:300858) — Market Cap & Net Worth
Market Cap & Net Worth: Beijing Scitop Bio Tech Co Ltd (300858)
Beijing Scitop Bio Tech Co Ltd (SHE:300858) has a market capitalization of $688.25 Million (CN¥4.70 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #10932 globally and #3231 in its home market, demonstrating a -20.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Scitop Bio Tech Co Ltd's stock price CN¥17.85 by its total outstanding shares 263495118 (263.50 Million). Analyse Beijing Scitop Bio Tech Co Ltd cash conversion from operations to see how efficiently the company converts income to cash.
Beijing Scitop Bio Tech Co Ltd Market Cap History: 2020 to 2026
Beijing Scitop Bio Tech Co Ltd's market capitalization history from 2020 to 2026. Data shows growth from $813.65 Million to $688.25 Million (7.31% CAGR).
Beijing Scitop Bio Tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Scitop Bio Tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.83x
Beijing Scitop Bio Tech Co Ltd's market cap is 1.83 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.88x
Beijing Scitop Bio Tech Co Ltd's market cap is 5.88 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $813.65 Million | $339.16 Million | $96.58 Million | 2.40x | 8.42x |
| 2021 | $813.69 Million | $364.62 Million | $109.54 Million | 2.23x | 7.43x |
| 2022 | $772.25 Million | $369.17 Million | $109.89 Million | 2.09x | 7.03x |
| 2023 | $736.59 Million | $299.24 Million | $93.48 Million | 2.46x | 7.88x |
| 2024 | $554.46 Million | $302.79 Million | $94.36 Million | 1.83x | 5.88x |
Competitor Companies of 300858 by Market Capitalization
Companies near Beijing Scitop Bio Tech Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Beijing Scitop Bio Tech Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Beijing Scitop Bio Tech Co Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Beijing Scitop Bio Tech Co Ltd's market cap moved from $813.65 Million to $ 688.25 Million, with a yearly change of 7.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥688.25 Million | +6.44% |
| 2025 | CN¥646.61 Million | +16.62% |
| 2024 | CN¥554.46 Million | -24.73% |
| 2023 | CN¥736.59 Million | -4.62% |
| 2022 | CN¥772.25 Million | -5.09% |
| 2021 | CN¥813.69 Million | 0.00% |
| 2020 | CN¥813.65 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Beijing Scitop Bio Tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $688.25 Million USD |
| MoneyControl | $688.25 Million USD |
| MarketWatch | $688.25 Million USD |
| marketcap.company | $688.25 Million USD |
| Reuters | $688.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Scitop Bio Tech Co Ltd
Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy … Read more